Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             95 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A coherent hypothesis of endogenous depression and schizophrenia 1999
9 S1 p. S16-
1 p.
artikel
2 Adenosine involvement in amitriptyline effect on glutamate and aspartate release in rat prefrontal cortex 1999
9 S1 p. S24-
1 p.
artikel
3 Aggression and dissociative symptoms in psychiatric outpatients 1999
9 S1 p. S18-
1 p.
artikel
4 Animal tests of anxiety: Clinical predictions 1999
9 S1 p. S1-
1 p.
artikel
5 Anti-anxiety activity — Involvement of serotonergic and GABA-ergic activity 1999
9 S1 p. S1-
1 p.
artikel
6 Association between VNTR polymorphism of the MAO-A gene and antisocial personality tendencies in male alcoholics 1999
9 S1 p. S19-S20
2 p.
artikel
7 Atypical antipsychotic drugs for the elderly: Is there evidence of efficacy and safety? 1999
9 S1 p. S11-
1 p.
artikel
8 Author index 1999
9 S1 p. S37-S38
2 p.
artikel
9 Bank of knowledge about healed depressive episodes — modern technologies in diagnosis and treatment 1999
9 S1 p. S14-
1 p.
artikel
10 Behavioural studies using chronic mild stress model of depression: The effect of housing 1999
9 S1 p. S24-
1 p.
artikel
11 Being restrained: A study of aggressiveness 1999
9 S1 p. S18-
1 p.
artikel
12 Benzodiazepines and sleep deprivation, both associated with a decrease in vigilance, induce differential effects on memory 1999
9 S1 p. S9-
1 p.
artikel
13 Bipolar 1 and bipolar II disorders: Variants of the same disorder, or distinct disorders? 1999
9 S1 p. S12-S13
2 p.
artikel
14 Bipolar II disorder is frequent in atypical depression 1999
9 S1 p. S13-
1 p.
artikel
15 Clinical utility of atypical neuroleptics 1999
9 S1 p. S3-
1 p.
artikel
16 Clorazepate (Tranxene) effectiveness in the treatment of uncomplicated alcohol withdrawal. A comparison with diazepam treatment in a randomized, controlled study 1999
9 S1 p. S12-
1 p.
artikel
17 Cognitive dysfunction in schizophrenia 1999
9 S1 p. S3-
1 p.
artikel
18 Colocalization of dopamine D1 receptors and tyrosine hydroxylase with glucocorticoid receptors 1999
9 S1 p. S31-
1 p.
artikel
19 Consequences of chronic mild stress on the recovery of function after sciatic nerve crush in individual male rats 1999
9 S1 p. S26-S27
2 p.
artikel
20 Cortical localisation of dopamine D4 receptors in the rat brain — Immunocytochemical studies 1999
9 S1 p. S30-S31
2 p.
artikel
21 Dependence on benzodiazepines 1999
9 S1 p. S4-S5
2 p.
artikel
22 Differential diagnosis and pharmacotherapy of “circumscriptae” catatonia. Case study 1999
9 S1 p. S11-
1 p.
artikel
23 Editorial Board 1999
9 S1 p. ii-
1 p.
artikel
24 Effect of chronic treatment with desipramine on the immunoreactivity of C57BL/6 mice subjected to a chronic stress model of depression 1999
9 S1 p. S25-
1 p.
artikel
25 Effect of nafadotride on (±)7-OH-DPAT-induced changes in locomotor activity of rats following repeated treatment with antidepressant drugs 1999
9 S1 p. S25-
1 p.
artikel
26 Effect of tramadol and clonidine on stress-induced analgesia 1999
9 S1 p. S33-
1 p.
artikel
27 Effects of calcium channel ligands on hypnotic activity of ethanol in mice 1999
9 S1 p. S27-S28
2 p.
artikel
28 Effects of flunarizine and verapamil on PTZ-kindling-provoked amnesia in rats 1999
9 S1 p. S28-S29
2 p.
artikel
29 Effects of 6-hydroxydopamine on c-fos and apoptosis in GDNF-treated meso-striatal organotypic co-cultures 1999
9 S1 p. S29-
1 p.
artikel
30 Effects of 17β-oestradiol on kainate toxicity in primary cortical neurons and in neuronally differentiated PC12 cells 1999
9 S1 p. S32-
1 p.
artikel
31 Effects of pharmacotherapy to depression in the period of adolescence 1999
9 S1 p. S15-S16
2 p.
artikel
32 Endogenous opioids and relapse 1999
9 S1 p. S3-S4
2 p.
artikel
33 Factors associated with the choice of cognitive-behaviour therapy alone and cognitive-behaviour therapy combined with pharmacotherapy in the treatment of panic disorder 1999
9 S1 p. S10-
1 p.
artikel
34 Functional outcomes in schizophrenia: A European comparison of olanzapine and haloperidol 1999
9 S1 p. S11-
1 p.
artikel
35 Gabapentin in acute mania 1999
9 S1 p. S14-
1 p.
artikel
36 Imipramine-induced decrease in the responsiveness of hippocampal pyramidal cells to group I metabotropic receptor activation 1999
9 S1 p. S27-
1 p.
artikel
37 Immune-receptor-endocrine interactions in the pathophysiology of major depression 1999
9 S1 p. S15-
1 p.
artikel
38 Influence of prolonged rTMS on cognitive functions and mood in healthy volunteers 1999
9 S1 p. S19-
1 p.
artikel
39 Investigations on effects of time varying magnetic field stimulation on the diurnal locomotor activity and learning processes of Syrian hamster 1999
9 S1 p. S34-
1 p.
artikel
40 Involvement of adrenergic neurotransmission in nociceptive activity of Tyr-MIF-1 1999
9 S1 p. S34-
1 p.
artikel
41 Involvement of histaminergic system in the antinociceptive effect of Tyr-MIF-1 1999
9 S1 p. S33-
1 p.
artikel
42 Involvement of nitric oxide in antinociceptive effect of newly synthesized analogues of Kyotorphin in rats 1999
9 S1 p. S32-S33
2 p.
artikel
43 Involvement of serotonin 5-HT1A receptors in the nucleus accumbens shell in cocaine-induced hyperlocomotion 1999
9 S1 p. S23-
1 p.
artikel
44 Negative immunoregulatory effects of antidepressants: Increased production of interleukin-10 1999
9 S1 p. S15-
1 p.
artikel
45 Neonatal blockade of NMDA receptors a novel model of experimental psychosis 1999
9 S1 p. S21-
1 p.
artikel
46 Neurodevelopmental aspects of schizophrenia, animal and human studies 1999
9 S1 p. S2-S3
2 p.
artikel
47 Neuroleptic malignant syndrome: Long term follow-up of two clinical cases. Differential diagnosis with catatonia 1999
9 S1 p. S12-
1 p.
artikel
48 Neuropeptide Y inhibits epileptiform activity in rat frontal cortex and hippocampus via different receptors 1999
9 S1 p. S32-
1 p.
artikel
49 Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats 1999
9 S1 p. S20-S21
2 p.
artikel
50 New functional agonists and antagonists of 5-HT1A receptors 1999
9 S1 p. S26-
1 p.
artikel
51 NMDA receptors and their ligands in animal models of depression 1999
9 S1 p. S6-
1 p.
artikel
52 Opioid mechanisms in drug addiction 1999
9 S1 p. S4-
1 p.
artikel
53 Opposite effects of imipramine and cocaine on the glucocorticoid receptor-mediated gene expression — An in vitro study 1999
9 S1 p. S22-
1 p.
artikel
54 Parkinsonian-like biochemical changes induced by chronic administration of endogenous substances: 1,2,3,4-tetrahydroisoquinoline and salsolinol 1999
9 S1 p. S29-S30
2 p.
artikel
55 Parkinson's disease: Biochemical investigation of adaptation processes in dopaminergic, serotonergic and noradrenergic structures within and outside of extrapyramidal system — A postmortem study 1999
9 S1 p. S16-
1 p.
artikel
56 Participation of opioid mechanism on the antinociceptive effect induced by (+)- and (−)- oxaprotiline in two behavioural pain tests in mice 1999
9 S1 p. S33-S34
2 p.
artikel
57 Polish algorithm for treatment of anxiety disorders 1999
9 S1 p. S9-S10
2 p.
artikel
58 Polish algorithm for treatment of obsessive-compulsive disorder 1999
9 S1 p. S9-
1 p.
artikel
59 Possibility of treatment — Impact of child trauma in stress reaction 1999
9 S1 p. S18-
1 p.
artikel
60 Psychomimetic activity of NMDA antagonists in behavioural and neurochemical models 1999
9 S1 p. S2-
1 p.
artikel
61 Psychopharmacological treatment and quality of life: Evaluation of social adaptation in a sample of out patients with anxiety and mood disorders 1999
9 S1 p. S14-
1 p.
artikel
62 Psychopharmacotherapy and community care in old age psychiatry 1999
9 S1 p. S20-
1 p.
artikel
63 Psychotomimetic effects of MK-801 are antagonized by CGP 40116, a competitive NMDA receptor antagonist 1999
9 S1 p. S22-
1 p.
artikel
64 Revealing of hereditary determined parameters of anxiety: Effect of ipsapirone 1999
9 S1 p. S20-
1 p.
artikel
65 Risk factors in schizophrenia 1999
9 S1 p. S10-S11
2 p.
artikel
66 SCH 58261, a selective adenosine A2A receptor antagonist with potential antiparkinsonian properties 1999
9 S1 p. S30-
1 p.
artikel
67 Serotonin receptors and transporter in schizophrenla 1999
9 S1 p. S1-S2
2 p.
artikel
68 Serum zinc and copper concentrations in unipolar depression 1999
9 S1 p. S13-S14
2 p.
artikel
69 Sleep complaint and psychopathology in primary care: A pilot study 1999
9 S1 p. S17-
1 p.
artikel
70 So-called “psychological dependence on benzodiazepines” 1999
9 S1 p. S12-
1 p.
artikel
71 Strategies for a faster onset of antidepressant activity 1999
9 S1 p. S6-
1 p.
artikel
72 TAU protein in Alzheimer's disease. Connection with age and the clinical stage of the disease 1999
9 S1 p. S18-
1 p.
artikel
73 The anticataleptic effect of 7-OH-DPAT: Are dopamine D3 receptors involved? 1999
9 S1 p. S30-
1 p.
artikel
74 The diurnal locomotor activity, general behavior and learning processes in mice exposed to magnetic field stimulation 1999
9 S1 p. S34-
1 p.
artikel
75 The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam 1999
9 S1 p. S35-
1 p.
artikel
76 The effect of antidepressant drugs on some immunological parameters of post-adjuvant polyarthritis in C57BL/6 mice 1999
9 S1 p. S25-
1 p.
artikel
77 The effect of some calcium antagonists on carbamazepine withdrawal syndrome in rats 1999
9 S1 p. S28-
1 p.
artikel
78 The effect of some sigma ligands on the cocaine-induced convulsions and locomotor hyperactivity 1999
9 S1 p. S23-
1 p.
artikel
79 The effects of chronic administration of typical and atypical antipsychotics on working memory, motor behavior and repetitive jaw movements (RJM) in young and aging rats 1999
9 S1 p. S21-
1 p.
artikel
80 The experience of using finlepsin to treat non-psychotic disorders of residual-organic genesis 1999
9 S1 p. S17-
1 p.
artikel
81 The impact of MK-801, a non-competitive NMDA receptor antagonist, on tyrosine hydroxylase 1999
9 S1 p. S31-S32
2 p.
artikel
82 The influence of mirtazapine on memory and other behavioural functions in rats 1999
9 S1 p. S26-
1 p.
artikel
83 The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of perazine 1999
9 S1 p. S23-S24
2 p.
artikel
84 The molecular target of antidepressants 1999
9 S1 p. S5-S6
2 p.
artikel
85 The pharmacokinetics of phenothiazine neuroleptics during chronic co-administration of carbamazepine 1999
9 S1 p. S21-S22
2 p.
artikel
86 The pharmacological effects of immunosuppressive therapy on multiple sclerosis (MS) affective disorders 1999
9 S1 p. S17-
1 p.
artikel
87 The prediction of antidepressant action from animal studies 1999
9 S1 p. S5-
1 p.
artikel
88 The prolonged rTMS: EEG activity and plasma hormone levels in healthy humans 1999
9 S1 p. S19-
1 p.
artikel
89 The proposal of the research method for a multiattribute evaluation in formulary decision making as applied to antidepressants and neuroleptics 1999
9 S1 p. S20-
1 p.
artikel
90 The role of 5-HT1B receptor in SSRIs mechanism of action 1999
9 S1 p. S6-S7
2 p.
artikel
91 The role of lysosomal trapping in the cellular distribution of perazine and in the pharmacokinetic interaction with antidepressants 1999
9 S1 p. S27-
1 p.
artikel
92 The use of pramipexole, a novel dopamine agonist, in rat models of parkinsonian-like muscle rigidity 1999
9 S1 p. S29-
1 p.
artikel
93 Thyroid hormones as an augmentation strategy in treatment-resistant depression 1999
9 S1 p. S13-
1 p.
artikel
94 Treatment of drug resistant depression 1999
9 S1 p. S7-
1 p.
artikel
95 Treatment resistance in schizophrenia 1999
9 S1 p. S3-
1 p.
artikel
                             95 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland